Cartalax is a synthetic bioregulator tripeptide (Ala-Glu-Asp) studied for its potential to support joint health, combat cartilage degradation, and slow cellular aging. Research suggests it helps restore cartilage cell function, promotes collagen and proteoglycan production, and reduces inflammatory joint tissue breakdown.

Primary Benefit and Mechanisms

• Matrix Synthesis: Cartalax is theorized to promote chondrocyte cell division and upregulate the production of Type II collagen and proteoglycans, the foundational structural components of cartilage.
Anti-inflammatory Effects: It may downregulate inflammatory cytokines (such as IL-1β and TNF-α) that drive cartilage breakdown and pain in conditions like osteoarthritis.
Cellular Longevity: Research suggests Cartalax may delay cellular senescence by modulating cell-cycle inhibitors (p16 and p21), allowing cartilage cells to maintain function under stress. [
Tissue Preservation: By stabilizing the extracellular matrix, it helps maintain connective tissue integrity against mechanical wear and tear.